Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Assist Reprod Genet ; 38(9): 2273-2282, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34286421

ABSTRACT

PURPOSE: Controlled ovarian stimulation significantly amplifies the number of maturing and ovulated follicles as well as ovarian steroid production. The ovarian hyperstimulation syndrome (OHSS) increases capillary permeability and fluid extravasation. Vascular integrity intensely is regulated by an endothelial glycocalyx (EGX) and we have shown that ovulatory cycles are associated with shedding of EGX components. This study investigates if controlled ovarian stimulation impacts on the integrity of the endothelial glycocalyx as this might explain key pathomechanisms of the OHSS. METHODS: Serum levels of endothelial glycocalyx components of infertility patients (n=18) undergoing controlled ovarian stimulation were compared to a control group of healthy women with regular ovulatory cycles (n=17). RESULTS: Patients during luteal phases of controlled ovarian stimulation cycles as compared to normal ovulatory cycles showed significantly increased Syndecan-1 serum concentrations (12.6 ng/ml 6.1125th-19.1375th to 13.9 ng/ml 9.625th-28.975th; p=0.026), indicating shedding and degradation of the EGX. CONCLUSION: A shedding of EGX components during ovarian stimulation has not yet been described. Our study suggests that ovarian stimulation may affect the integrity of the endothelial surface layer and increasing vascular permeability. This could explain key features of the OHSS and provide new ways of prevention of this serious condition of assisted reproduction.


Subject(s)
Capillary Permeability , Endothelium, Vascular/metabolism , Glycocalyx/metabolism , Infertility, Female/pathology , Ovulation Induction/methods , Syndecan-1/metabolism , Adult , Case-Control Studies , Female , Humans , Infertility, Female/metabolism , Pilot Projects
2.
Internist (Berl) ; 54(11): 1376-82, 2013 Nov.
Article in German | MEDLINE | ID: mdl-24026792

ABSTRACT

A 49-year-old woman presented with unspecific symptoms including polydipsia, increasing fatigue for several weeks, and vague abdominal pain. Serum calcium (5.30 mmol/l; normal range 2.00-2.60) and parathyroid hormone levels (> 2500.0 ng/l; normal range 15.0-68.0) were extremely elevated. Imaging studies showed a huge mediastinal tumor. Based on these findings a hypercalcemic crisis caused by primary hyperparathyroidism was diagnosed. After intensive care treatment and further diagnostic procedures, the patient's parathyroid adenoma was removed by parathyroidectomy. The postoperative course was uneventful.


Subject(s)
Abdominal Pain/etiology , Adenoma/complications , Adenoma/diagnosis , Fatigue/etiology , Parathyroid Neoplasms/complications , Parathyroid Neoplasms/diagnosis , Polydipsia/etiology , Abdominal Pain/diagnosis , Abdominal Pain/prevention & control , Adenoma/surgery , Diagnosis, Differential , Fatigue/diagnosis , Fatigue/prevention & control , Female , Humans , Mediastinal Neoplasms , Middle Aged , Parathyroid Neoplasms/surgery , Parathyroidectomy , Polydipsia/diagnosis , Polydipsia/prevention & control , Treatment Outcome
3.
Orthopade ; 41(6): 477-81, 2012 Jun.
Article in German | MEDLINE | ID: mdl-22638598

ABSTRACT

Coronary stenting is an effective treatment for reopening atherosclerotic occlusions of coronary arteries. Depending on the manifestation of coronary artery disease (stable CAD or acute coronary syndrome) and on the type of implanted stent, dual antiplatelet therapy is recommended for a period of 4 weeks to 12 months. In this period total joint replacement is associated with high blood loss and high perioperative morbidity. Therefore antiplatelet therapy is often discontinued and replaced by higher dosages of heparin for prophylactic anticoagulation. However, with this treatment regimen protection of the stent is doubtful and there is a high risk of stent thrombosis with myocardial infarction. The surgery should be scheduled after the dual antiplatelet therapy is replaced by lifelong aspirin therapy. On the other hand, if surgery cannot be postponed perioperative bridging of dual antiplatelet therapy can be conducted to minimize bleeding complications with the best possible stent protection. Lifelong therapy with aspirin should not be discontinued in any case.


Subject(s)
Angioplasty, Balloon, Coronary , Arthroplasty, Replacement, Hip , Arthroplasty, Replacement, Knee , Coronary Disease/therapy , Platelet Aggregation Inhibitors/adverse effects , Platelet Aggregation Inhibitors/therapeutic use , Platelet Function Tests , Postoperative Complications/drug therapy , Stents , Anticoagulants/adverse effects , Anticoagulants/therapeutic use , Aspirin/adverse effects , Aspirin/therapeutic use , Blood Loss, Surgical , Comorbidity , Coronary Disease/blood , Dose-Response Relationship, Drug , Drug Substitution , Drug Therapy, Combination , Hemorrhage/blood , Hemorrhage/chemically induced , Hemorrhage/prevention & control , Heparin/adverse effects , Heparin/therapeutic use , Humans , Long-Term Care , Postoperative Complications/blood , Reoperation
4.
Article in German | MEDLINE | ID: mdl-10665320

ABSTRACT

We are reporting the case of a female patient who had to undergo splenectomy after she suffered splenic rupture as a result from "kinetic therapy" during the treatment for pulmonary failure secondary to sepsis. Four years later the patient was again admitted with a clinical picture consistent with sepsis. Two blood cultures were positive for pneumococci confirming the diagnosis of pneumococcal sepsis. This paper discusses the potential risks of kinetic therapy in patients with ARDS. After splenectomy there is increased risk of infection with certain bacteria, funghi, viruses and protozoa. The most common bacterial pathogen is pneumococcus. A polyvalent vaccine is available for prophylaxis. Although penicillin G is still commonly used as an antibiotic therapy for pneumococcal infection, increased resistance of pathogens to penicillin must be anticipated. Alternative antibiotic regimens are demonstrated.


Subject(s)
Physical Therapy Modalities/adverse effects , Pneumonia, Pneumococcal/complications , Prone Position , Respiratory Distress Syndrome/therapy , Respiratory Therapy , Sepsis/complications , Spleen/injuries , Female , Humans , Middle Aged , Respiratory Distress Syndrome/etiology , Rupture , Splenectomy
SELECTION OF CITATIONS
SEARCH DETAIL
...